Rational Advisors LLC Biogen Inc. Transaction History

Rational Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $16,065 - $24,182	-68 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $32,831 - $37,908	-124 Reduced 64.58%	68 $19,000
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $49,662 - $65,769	192 New	192 $51,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $119,100 - $151,080	-443 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $16,504 - $22,805	75 Added 20.38%	443 $131,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $31,311 - $35,118	-144 Reduced 28.13%	368 $86,000
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $106,574 - $117,475	486 Added 1869.23%	512 $120,000
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $5,634 - $8,812	26 New	26 $6,000
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $20,887 - $26,456	-75 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$293.51 - $383.83 $152,331 - $199,207	-519 Reduced 87.37%	75 $26,000
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $9,013 - $10,741	-35 Reduced 5.56%	594 $172,000
Q1 2018 May 18, 2018	BUY	$260.13 - $367.91 $9,364 - $13,244	36 Added 6.07%	629 $172,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $166,721 - $195,506	593	593 $186,000

1,018

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.